Live Breaking News & Updates on Enlivex Therapeutics Ltd View

Stay updated with breaking news from Enlivex therapeutics ltd view. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Enlivex Therapeutics Ltd.: Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials

NES-ZIONA, ISRAEL / ACCESSWIRE / April 14, 2023 / This month, H.C. Wainwright & Co. reiterated its buy rating for Enlivex Therapeutics Ltd. (NASDAQ:ENLV) with a 12-month price target of $15 per share, ....

Beigene Tislelizumab , Shachar Shlosberger , Enlivex Therapeutics Ltd , National Cancer Institute , Hc Wainwright Co , Bristol Myers Squibb , Enlivex Therapeutics Ltd View , Beigene Ltd , Enlivex Therapeutics , Therapeutics Ltd , Cancer Institute , Nektar Therapeutic ,